Sangamo Therapeutics, Inc. (SGMO)
USD 2.35
(-16.67%)
USD 2.35
(-16.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -224.84 Million | -223.62 Million | -233.25 Million | 169.87 Million | -144.4 Million | 37.15 Million |
| Net Income | -257.83 Million | -192.27 Million | -178.29 Million | -121.12 Million | -95.41 Million | -68.88 Million |
| Depreciation & Amortization | 22.19 Million | 20.56 Million | 17.63 Million | 13.36 Million | 9.6 Million | 2.35 Million |
| Deferred income taxes | -6.33 Million | - | 2.77 Million | - | -5.12 Million | -5.22 Million |
| Stock-based compensation | 27.36 Million | 31.65 Million | 32.95 Million | 25.7 Million | 19.33 Million | 14.67 Million |
| Change in working capital | -164.03 Million | -82.31 Million | -101.89 Million | 252.58 Million | -73.01 Million | 93.26 Million |
| Other non-cash items | 153.8 Million | -1.24 Million | -6.42 Million | -666 Thousand | 218 Thousand | 966 Thousand |
| Investing Cash Flow | 153.53 Million | 59.28 Million | 248.19 Million | -271.62 Million | -59.8 Million | -178.1 Million |
| Investments in PPE | -21.15 Million | -20.17 Million | -23.27 Million | -14.71 Million | -20.67 Million | -43.06 Million |
| Acquisitions | - | -79.45 Million | -119 Thousand | -704 Thousand | -262 Thousand | -75.64 Million |
| Investment purchases | -59.55 Million | -277.39 Million | -338.15 Million | -570.77 Million | -443.71 Million | -451.23 Million |
| Sales/Maturities of investments | 234.23 Million | 356.84 Million | 609.75 Million | 314.57 Million | 404.84 Million | 391.84 Million |
| Other Investing Activities | 174.68 Million | 79.45 Million | -119 Thousand | -704 Thousand | -262 Thousand | -59.39 Million |
| Financing Cash Flow | 14.58 Million | 84.66 Million | 32.85 Million | 153.1 Million | 142.02 Million | 231.7 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.45 Million | -2.1 Million | 3.36 Million | -765 Thousand | -422 Thousand | -254 Thousand |
| Common Stock Issuance | 16.04 Million | 86.76 Million | 27.09 Million | 153.86 Million | 142.45 Million | 231.96 Million |
| Other Financing Activities | 16.04 Million | 86.76 Million | 2.39 Million | 153.86 Million | 142.45 Million | -254 Thousand |
| Accounts receivables | 3.14 Million | 2.33 Million | -789 Thousand | 31.68 Million | -32.23 Million | -1.33 Million |
| Accounts payables | 5.58 Million | 13.34 Million | -7.66 Million | 10.7 Million | -4.19 Million | -6.37 Million |
| Inventory | - | - | 7.66 Million | -10.7 Million | 4.19 Million | -1 Million |
| Other working capital | -172.77 Million | -98 Million | -101.1 Million | 220.9 Million | -40.77 Million | 101.96 Million |
| Cash at beginning of period | 100.44 Million | 180.37 Million | 132.82 Million | 81.92 Million | 143.91 Million | 53.32 Million |
| Cash at end of period | 45.2 Million | 101.94 Million | 180.37 Million | 132.82 Million | 81.92 Million | 143.91 Million |
| Capital Expenditure | -21.15 Million | -20.17 Million | -23.27 Million | -14.71 Million | -20.67 Million | -43.06 Million |
| Effect of forex changes on cash | 1.48 Million | 1.25 Million | -263 Thousand | -447 Thousand | 184 Thousand | -163 Thousand |
| Net cash flow / Change in cash | -55.24 Million | -78.42 Million | 47.54 Million | 50.9 Million | -61.99 Million | 90.59 Million |
| Free Cash Flow | -245.99 Million | -243.79 Million | -256.52 Million | 155.16 Million | -165.07 Million | -5.91 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -36.12 Million | -49.08 Million | -60.29 Million | -257.83 Million | -104.16 Million | -114.5 Million |
| Depreciation & Amortization | 2.57 Million | 2.52 Million | 2.98 Million | 22.19 Million | 7.42 Million | 6.18 Million |
| Deferred income taxes | - | - | -140 Thousand | -6.33 Million | 182 Thousand | 50.68 Million |
| Stock-based compensation | 3.06 Million | 2.71 Million | 6.1 Million | 27.36 Million | 6.18 Million | 6.79 Million |
| Change in working capital | 2.53 Million | -8.89 Million | 783 Thousand | -164.03 Million | -2.67 Million | -3.33 Million |
| Other non-cash items | 8.86 Million | 16.2 Million | 26 Thousand | 153.8 Million | 45.75 Million | -6.53 Million |
| Investing Cash Flow | 127 Thousand | 35.84 Million | 37.7 Million | 153.53 Million | 37.62 Million | 42.46 Million |
| Investments in PPE | - | - | -2.67 Million | -21.15 Million | -2.74 Million | -5.54 Million |
| Acquisitions | - | - | 134.3 Million | - | -40.37 Million | -48 Million |
| Investment purchases | - | - | - | -59.55 Million | -7.43 Million | -15.88 Million |
| Sales/Maturities of investments | - | 35.84 Million | 40.37 Million | 234.23 Million | 47.81 Million | 63.89 Million |
| Other Investing Activities | 127 Thousand | 35.84 Million | 40.37 Million | 174.68 Million | 40.37 Million | 48 Million |
| Financing Cash Flow | -533 Thousand | 22.12 Million | 167 Thousand | 14.58 Million | -100 Thousand | 6.51 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 146 Thousand | -402 Thousand | -49 Thousand | -1.45 Million | -101 Thousand | -194 Thousand |
| Common Stock Issuance | -454 Thousand | 22.52 Million | 216 Thousand | 16.04 Million | 15.1 Million | 719 Thousand |
| Other Financing Activities | -79 Thousand | -402 Thousand | 216 Thousand | 16.04 Million | 1000.00 | 6.71 Million |
| Accounts receivables | 126 Thousand | 586 Thousand | 425 Thousand | 3.14 Million | 1.56 Million | 4.31 Million |
| Accounts payables | 285 Thousand | -4.93 Million | 10.8 Million | 5.58 Million | -2.11 Million | -1.19 Million |
| Inventory | - | - | -3.31 Million | - | 2.11 Million | 1.19 Million |
| Other working capital | 2.12 Million | -4.54 Million | -10.45 Million | -172.77 Million | -4.24 Million | -7.64 Million |
| Cash at beginning of period | 55.33 Million | 45.2 Million | 56.51 Million | 100.44 Million | 68.33 Million | 79.74 Million |
| Cash at end of period | 27.78 Million | 55.33 Million | 45.2 Million | 45.2 Million | 58.01 Million | 68.33 Million |
| Capital Expenditure | - | - | -2.67 Million | -21.15 Million | -2.74 Million | -5.54 Million |
| Effect of forex changes on cash | -257 Thousand | -670 Thousand | 1.35 Million | 1.48 Million | -550 Thousand | 313 Thousand |
| Net cash flow / Change in cash | -27.54 Million | 10.12 Million | -11.31 Million | -55.24 Million | -10.31 Million | -11.41 Million |
| Free Cash Flow | -26.88 Million | -48.66 Million | -53.2 Million | -245.99 Million | -50.03 Million | -66.25 Million |
6977
010955
AVONMORE
FMCKP
EDR
AGUAS-A